Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
45,428,913
-
Share change
-
+23,272,451
-
Total reported value
-
$39,974,087
-
Put/Call ratio
-
34%
-
Price per share
-
$0.88
-
Number of holders
-
50
-
Value change
-
+$20,640,649
-
Number of buys
-
29
-
Number of sells
-
16
Institutional Holders of HOOKIPA PHARMA - COM (HOOK) as of Q2 2023
As of 30 Jun 2023,
HOOKIPA PHARMA - COM (HOOK) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,428,913 shares.
The largest 10 holders included
Artal Group S.A., Knoll Capital Management, LLC, FMR LLC, EcoR1 Capital, LLC, BAKER BROS. ADVISORS LP, ARMISTICE CAPITAL, LLC, Redmile Group, LLC, Alyeska Investment Group, L.P., VANGUARD GROUP INC, and Walleye Capital LLC.
This page lists
52
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.